News Announcement

Morepen Laboratories: Board Meeting Intimation for Q3-FY 26 Unaudited Financial Results

Morepen Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 inter alia to consider and approve Q3-FY 26 Unaudited Financial Results

Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.